Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM04WVH)

Drug Name
5-Carbazol-9-yl-pentanoic acid Drug Info
Synonyms CHEMBL184795; 5-Carbazol-9-yl-pentanoic acid; SCHEMBL12951764; BDBM50152858
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
28971834
TTD Drug ID
DM04WVH

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Fatty acid-binding protein 4 (FABP4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Fatty acid-binding protein 5 (FABP5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
PMID27109571-Compound-27 DMXRTH4 N. A. N. A. Patented [2]
PMID27109571-Compound-31 DMU690T N. A. N. A. Patented [2]
PMID27109571-Compound-16 DMZI25U N. A. N. A. Patented [2]
PMID27109571-Compound-14 DMVY6B9 N. A. N. A. Patented [2]
PMID27109571-Compound-25 DM435GR N. A. N. A. Patented [2]
PMID27109571-Compound-30 DM24FSP N. A. N. A. Patented [2]
PMID27109571-Compound-29 DMDMEHQ N. A. N. A. Patented [2]
PMID27109571-Compound-18 DM4S5ME N. A. N. A. Patented [2]
PMID27109571-Compound-28 DMTZVY3 N. A. N. A. Patented [2]
PMID27109571-Compound-20 DMQU9XP N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fatty acid-binding protein 4 (FABP4) TTHWMFZ FABP4_HUMAN Inhibitor [1]
Fatty acid-binding protein 5 (FABP5) TTNT2S6 FABP5_HUMAN Inhibitor [1]

References

1 Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
2 Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.